Exploring the Pharmacological Mechanism of Duhuo Jisheng Decoction in Treating Osteoporosis Based on Network Pharmacology

被引:22
|
作者
Xiong, Zhencheng [1 ,2 ]
Zheng, Can [3 ]
Chang, Yanan [4 ]
Liu, Kuankuan [4 ]
Shu, Li [4 ]
Zhang, Chi [1 ,3 ,4 ,5 ,6 ]
机构
[1] Peking Univ, Inst Med Technol, Hlth Sci Ctr, Beijing, Peoples R China
[2] Peking Univ Third Hosp, Beijing, Peoples R China
[3] Peking Univ, Biomed Engn Dept, Beijing, Peoples R China
[4] Peking Univ Int Hosp, Cent Lab, Beijing, Peoples R China
[5] Peking Univ Int Hosp, Dept Orthoped, Beijing, Peoples R China
[6] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China
关键词
OSTEOGENIC DIFFERENTIATION; STEM-CELLS; DATABASE;
D O I
10.1155/2021/5510290
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. The purpose of this work is to study the mechanism of action of Duhuo Jisheng Decoction (DHJSD) in the treatment of osteoporosis based on the methods of bioinformatics and network pharmacology. Methods. In this study, the active compounds of each medicinal ingredient of DHJSD and their corresponding targets were obtained from TCMSP database. Osteoporosis was treated as search query in GeneCards, MalaCards, DisGeNET, Therapeutic Target Database (TTD), Comparative Toxicogenomics Database (CTD), and OMIM databases to obtain disease-related genes. The overlapping targets of DHJSD and osteoporosis were identified, and then GO and KEGG enrichment analysis were performed. Cytoscape was employed to construct DHJSD-compounds-target genes-osteoporosis network and protein-protein interaction (PPI) network. CytoHubba was utilized to select the hub genes. The activities of binding of hub genes and key components were confirmed by molecular docking. Results. 174 active compounds and their 205 related potential targets were identified in DHJSD for the treatment of osteoporosis, including 10 hub genes (AKT1, ALB, IL6, MAPK3, VEGFA, JUN, CASP3, EGFR, MYC, and EGF). Pathway enrichment analysis of target proteins indicated that osteoclast differentiation, AGE-RAGE signaling pathway in diabetic complications, Wnt signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, calcium signaling pathway, and TNF signaling pathway were the specifically major pathways regulated by DHJSD against osteoporosis. Further verification based on molecular docking results showed that the small molecule compounds (Quercetin, Kaempferol, Beta-sitosterol, Beta-carotene, and Formononetin) contained in DHJSD generally have excellent binding affinity to the macromolecular target proteins encoded by the top 10 genes. Conclusion. This study reveals the characteristics of multi-component, multi-target, and multi-pathway of DHJSD against osteoporosis and provides novel insights for verifying the mechanism of DHJSD in the treatment of osteoporosis.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] The mechanism of Bushen Huoxue decoction in treating intervertebral disc degeneration based on network pharmacology
    Feng, Shuai-Hua
    Xie, Fang
    Yao, Hong-Yan
    Wu, Guan-Bao
    Sun, Xiang-Yun
    Yang, Jie
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (04) : 3783 - 3792
  • [32] Efficacy of Duhuo Jisheng Decoction for Treating Cold-Dampness Obstruction Syndrome-Type Knee Osteoarthritis: A Pooled Analysis
    Zhao, Jinlong
    Liang, Guihong
    Pan, Jianke
    Yang, Weiyi
    Zeng, Lingfeng
    Liu, Jun
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [33] Exploring the pharmacological mechanism of Artemisia annua herba based on network pharmacology
    Bai, Yuting
    Xie, Yulei
    Zhong, Xiaowu
    Luo, Can
    Wu, Qing
    Chen, Xin
    INTERNATIONAL JOURNAL OF DATA MINING AND BIOINFORMATICS, 2024, 28 (01) : 73 - 90
  • [34] Study on the action mechanism of Wuling Powder on treating osteoporosis based on network pharmacology
    ZHOU Hao-Nan
    LI Hao-Yu
    XU Wen-Hua
    WEI Yan-Yi
    YU Rui-Xin
    WANG Wei
    CHEN Yuan-Ming
    Chinese Journal of Natural Medicines, 2021, 19 (01) : 28 - 35
  • [35] Study on the action mechanism of Wuling Powder on treating osteoporosis based on network pharmacology
    Zhou Hao-Nan
    Li Hao-Yu
    Xu Wen-Hua
    Wei Yan-Yi
    Yu Rui-Xin
    Wang Wei
    Chen Yuan-Ming
    CHINESE JOURNAL OF NATURAL MEDICINES, 2021, 19 (01) : 28 - 35
  • [36] Exploring the mechanism of Jingshen Xiaoke decoction in treating T2DM mice based on network pharmacology and molecular docking
    Maoa, Yongpo
    Pana, Shengwang
    Song, Yiming
    Wang, Wenxiang
    Li, Ning
    Feng, Binbin
    Zhang, Jianhai
    TECHNOLOGY AND HEALTH CARE, 2024, 32 (01) : 163 - 179
  • [37] Analysis of the pharmacological mechanism of Roucongrong in treating osteoporosis based on a biological network module
    Lin, De-Min
    Xie, Xing-Wen
    Li, Ding-Peng
    Xu, Wei
    Li, Jing
    Lu, He-Zhong
    Huang, Rui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 14 (09): : 2359 - 2368
  • [38] Exploring the potential mechanism of Huanglian Jiedu Decoction against sepsis based on network pharmacology
    Liu Yarong
    Li Shutong
    Jiang Yu
    Zou Lianhong
    Cheng Ting
    Liu Yanjuan
    实用休克杂志(中英文), 2022, 6 (02) : 123 - 128
  • [39] Exploring the mechanism of Suanzaoren decoction in treatment of insomnia based on network pharmacology and molecular docking
    Wang, Shuxiao
    Zhao, Yan
    Hu, Xingang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [40] Exploring the mechanism of Erchen decoction in the treatment of atherosclerosis based on network pharmacology and molecular docking
    Li, Wenwen
    Zhang, Guowei
    Zhao, Zhenfeng
    Zuo, Yaoyao
    Sun, Zhenhai
    Chen, Shouqiang
    MEDICINE, 2023, 102 (46) : E35248